135321-83-4

Upstream product

• 33233-67-9 4-(tert-Butoxycarbonylaminomethyl)benzoic acid 
• 14529-00-1 benzyl 3-aminopropionate 

Downstream Products

• 566180-31-2 Boc-Phe-oxymethoxycarbonyl-4-(aminomethyl)benzoyl-β-Ala-Asp(OBzl)-OTce 
• 566180-41-4 Boc-(4-aminomethylbenzoyl)-β-Ala-Asp(OBzl)-Phe-OBzl 
• 566180-32-3 Boc-Phe-oxymethoxycarbonyl-4-(aminomethyl)benzoyl-β-Ala-Asp(OBzl)-OH 
• 566180-34-5 ((9S,12S)-9-Benzyl-4,8,11,14,18-pentaoxo-5,7-dioxa-3,10,13,17-tetraaza-bicyclo[17.2.2]tricosa-1⁽²²⁾,19⁽²³⁾,20-trien-12-yl)-acetic acid benzyl ester 
• 566180-42-5 Boc-(4-aminomethylbenzoyl)-β-Ala-Asp-Phe-OH 
• 566180-38-9 Boc-Phe-oxymethoxycarbonyl-4-(aminomethyl)benzoyl-β-Ala-OBzl 
• 566180-28-7 4-(N-Boc-aminomethyl)benzoyl-β-Ala-Asp(OBzl)-OTce 
• 566180-39-0 Boc-Phe-oxymethoxycarbonyl-4-(aminomethyl)benzoyl-β-Ala-OH 
• 566180-36-7 N-[4-[[[(chloromethoxy)carbonyl]amino]methyl]benzoyl]-β-alanine benzyl ester 
• 566180-27-6 N-[4-(N-t-butyloxycarbonyl-aminomethyl)benzoyl]-β-alanine 
• 566180-35-6 N-[4-(aminomethyl)benzoyl]-β-alanine benzyl ester 

Relevant academic research and scientific papers

Synthesis and comparison of physicochemical, transport, and antithrombic properties of a cyclic prodrug and the parent RGD peptidomimetic

Cyclic prodrug 1 was derived from RGD peptidomimetic 2 by linking the amino and carboxylic acid groups via an (acyloxy)alkoxy linker. The formation of a cyclic prodrug can transiently alter the physicochemical properties of the RGD peptidomimetic. Cyclic

Novel benzoic and phenylacetic acid derivatives

The compound of the formula STR1 wherein R1, R2 and R3 have the significance given in the description, can be used as medicaments for the therapy and prophylaxis of disorders such as thromboses, stroke, cardiac infarct, inflammations and arteriosclerosis as well as for the treatment of tumours.